Home>Event & Press

Event & Press

Event & Press
Research Achievements of Merck Collaborating with Primed Biotech Were Presented at ADA 2018

On June 22nd to 26th, 2018, the research achievements of MSD collaborating with Primed Shines were presented at ADA 78th Scientific Sessions in Orlando. We reported the study of “Deep phenotyping of a spontaneous nonhuman primate model of diabetic macular edema (DME)”. Primed’s NHP model can provide a clinically translatable large animal model for DME research and treatment evaluation. Primed’s NHPs allow us to deepen our understanding of DME and offer better identification of non-responders to anti-VEGF drugs for exploring new opportunities in DME treatment. VEGF can be used as surrogate biomarkers for early detection of DME.

<Return

Connect